导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 32.53% | 671/2269 |
| 近一周 | 0.23% | 1071/2338 |
| 近一月 | -1.32% | 1571/2330 |
| 近一季 | 2.00% | 808/2324 |
| 近半年 | 20.10% | 908/2303 |
| 近一年 | 27.10% | 669/2260 |
| 近两年 | 54.40% | 292/2185 |
| 近三年 | 45.53% | 221/2063 |
| 成立以来 | 431.66% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
7.39% 346/2331 |
3.40% 681/2353 |
21.25% 927/2347 |
- - |
| 2024 | 17.41% 179/2336 |
-3.30% 1457/2322 |
-5.45% 1804/2326 |
22.99% 49/2322 |
4.42% 319/2336 |
| 2023 | -3.41% 736/2330 |
10.43% 222/2290 |
-2.24% 1158/2303 |
-6.21% 1278/2318 |
-4.60% 1417/2330 |
| 2022 | -18.45% 1220/2299 |
-16.13% 1342/2227 |
6.35% 851/2269 |
-13.26% 1720/2294 |
5.40% 226/2300 |
| 2021 | 89.03% 4/2205 |
22.59% 4/2009 |
19.65% 299/2060 |
20.62% 43/2103 |
6.85% 341/2208 |
| 2020 | 61.23% 483/2086 |
3.79% 294/1861 |
15.21% 940/1950 |
12.30% 600/2010 |
20.07% 258/2031 |
| 2019 | 52.58% 270/1974 |
37.51% 120/3053 |
-5.02% 2559/3201 |
7.85% 432/1861 |
8.32% 684/1886 |
| 2018 | -14.93% 823/1913 |
- - |
2.39% 125/2983 |
-10.26% 2614/2970 |
-8.62% 1701/2975 |
| 2017 | 9.64% 563/1885 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8141 | 37.76% |
| 易方达标普生物科技人民币A | 1.7328 | 28.02% |
| 永赢先锋半导体智选混合发起C | 1.2684 | 26.99% |
| 银华集成电路混合A | 1.4951 | 23.93% |
| 华商致远回报混合A | 1.6291 | 23.20% |
| 华夏中证半导体材料设备主题ETF | 1.5851 | 22.62% |
| 天弘中证半导体材料设备主题指数发起C | 1.7561 | 21.34% |
| 诺安优化配置混合A | 2.5072 | 17.29% |
| 东方低碳经济混合C | 1.2657 | 17.06% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 16.76% |
| 广发多因子混合 VS. () |